Clinical Trial: Absorption and Tolerability of Injectable Administration of Niagen(R)+, as Compared to NAD+

U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT06919328) titled 'Absorption and Tolerability of Injectable Administration of Niagen(R)+, as Compared to NAD+' on March 19.

Brief Summary: This study evaluates the subjective effects of injection administration of NR on healthy adult populations.

Study Start Date: Oct. 31, 2024

Study Type: INTERVENTIONAL

Condition: Healthy Aging

Intervention: DIETARY_SUPPLEMENT: Niagen(R)

nicotinamide riboside

OTHER: NAD+

Nicotinamide adenine dinucleotide

OTHER: Placebo

bacteriostatic water

Recruitment Status: RECRUITING

Sponsor: Nutraceuticals Research Institute

Information provided by (Responsible Party): Jessie Hawkins, Nutraceuticals Research Insti...